1. Home
  2. GRABW vs CGEN Comparison

GRABW vs CGEN Comparison

Compare GRABW & CGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRABW
  • CGEN
  • Stock Information
  • Founded
  • GRABW 2012
  • CGEN 1993
  • Country
  • GRABW Singapore
  • CGEN Israel
  • Employees
  • GRABW 11267
  • CGEN N/A
  • Industry
  • GRABW Business Services
  • CGEN Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • GRABW Consumer Discretionary
  • CGEN Health Care
  • Exchange
  • GRABW Nasdaq
  • CGEN Nasdaq
  • Market Cap
  • GRABW N/A
  • CGEN 167.4M
  • IPO Year
  • GRABW N/A
  • CGEN 2000
  • Fundamental
  • Price
  • GRABW N/A
  • CGEN $1.76
  • Analyst Decision
  • GRABW
  • CGEN
  • Analyst Count
  • GRABW 0
  • CGEN 0
  • Target Price
  • GRABW N/A
  • CGEN N/A
  • AVG Volume (30 Days)
  • GRABW 54.7K
  • CGEN 181.3K
  • Earning Date
  • GRABW 02-21-2025
  • CGEN 08-05-2025
  • Dividend Yield
  • GRABW N/A
  • CGEN N/A
  • EPS Growth
  • GRABW N/A
  • CGEN N/A
  • EPS
  • GRABW N/A
  • CGEN N/A
  • Revenue
  • GRABW $2,686,000,000.00
  • CGEN $27,589,000.00
  • Revenue This Year
  • GRABW N/A
  • CGEN N/A
  • Revenue Next Year
  • GRABW N/A
  • CGEN $173.80
  • P/E Ratio
  • GRABW N/A
  • CGEN N/A
  • Revenue Growth
  • GRABW 21.65
  • CGEN N/A
  • 52 Week Low
  • GRABW $0.15
  • CGEN $1.13
  • 52 Week High
  • GRABW $0.59
  • CGEN $2.66
  • Technical
  • Relative Strength Index (RSI)
  • GRABW 53.67
  • CGEN 59.85
  • Support Level
  • GRABW $0.33
  • CGEN $1.62
  • Resistance Level
  • GRABW $0.40
  • CGEN $1.81
  • Average True Range (ATR)
  • GRABW 0.02
  • CGEN 0.08
  • MACD
  • GRABW 0.00
  • CGEN 0.00
  • Stochastic Oscillator
  • GRABW 94.29
  • CGEN 78.26

About GRABW Grab Holdings Limited Warrant

Founded in 2012, Grab provides ride-sharing services, food and grocery delivery, and financial services (payments, consumer loans, and enterprise offerings) in eight Southeast-Asian countries through its mobile platform. The company partners with merchants and riders, connecting them with consumers while charging commission to both sides. Grab has a leading market share in and derives 89% of its revenue from its core businesses, ride-sharing and food delivery. Singapore and Malaysia contributed 58% of revenue as of end-2021. Grab's main competitors in Southeast Asia are Foodpanda and Gojek, the ride-sharing arm of GoTo. Its financial services business is still in its nascent stage and provides minimal revenue currently. The company now also generates advertising revenue.

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

Share on Social Networks: